- Recent Advances for Anti-Obesity Agents
-
Kim CS
- KMID: 2173852
- J Korean Diabetes.
- 2015 Dec;16(4):260-268.
- doi: 10.4093/jkd.2015.16.4.260
Obesity is one of the most significant risk factor for diabetes, cardiovascular disease, malignancy and other chronic diseases. The obesity and its associated conditions is one of the most urgent... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Treatments on Obesity
-
Lee CJ, Kim MJ, An SJ
- KMID: 2469164
- Korean J Health Promot.
- 2019 Dec;19(4):171-185.
- doi: 10.15384/kjhp.2019.19.4.171
Recently, the number of obesity and diabetes mellitus have increased rapidly not only in Korea but also around the world. It is even called the new pandemic of the 21st... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advances in Anti-Obesity Agents
-
Kim MK, Kim CS
- KMID: 2438040
- Korean J Med.
- 2018 Dec;93(6):501-508.
- doi: 10.3904/kjm.2018.93.6.501
Obesity is a chronic disorder that is a significant risk factor for diabetes, cardiovascular diseases, malignancy, and other chronic diseases. Lifestyle modifications form the basis of most treatments for obesity,... -
- CITED
-
- Close
- SHARE
-
- Close
- New and emerging drugs for the treatment of obesity
-
Roh E, Kim MS
- KMID: 2195041
- J Korean Med Assoc.
- 2015 May;58(5):452-457.
- doi: 10.5124/jkma.2015.58.5.452
Obesity has become a global public health problem. The importance of obesity is highlighted by the fact that obesity-related comorbidities, such as type 2 diabetes, cardiovascular disease, and cancer, are... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Obesity with Drugs
-
Kim SM
- KMID: 2183464
- J Korean Med Assoc.
- 2004 Apr;47(4):361-368.
- doi: 10.5124/jkma.2004.47.4.361
Oesity is a major global health problem. However, current therapeutic strategies for obesity are limited. Obesity results from an imbalance between energy intake and energy expenditure, and the treatment of... -
- CITED
-
- Close
- SHARE
-
- Close
- Drug Therapy for Obesity
-
Kim KS, Park SW
- KMID: 2270999
- Korean J Obes.
- 2012 Dec;21(4):197-202.
Obesity is associated with a substantial increase in metabolic disorders and various cancers. As weight loss achieved with lifestyle intervention is modest, there is a need for drug treatment. Orlistat, phentermine,... -
- CITED
-
- Close
- SHARE
-
- Close
- Attitudes and Reported Practice for Obesity Management in Korea After Introduction of Anti-obesity Agents
-
Park HS, Park JY, Cho HJ
- KMID: 1781715
- J Korean Med Sci.
- 2005 Feb;20(1):1-6.
- doi: 10.3346/jkms.2005.20.1.1
This study aimed to evaluate current clinical assessments and management of obesity in the primary care setting in Korea since anti-obesity agents have become available. A questionnaire was sent to... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-Obesity Drugs: A Review about Their Effects and Safety
-
Kang JG, Park CY
- KMID: 2281424
- Diabetes Metab J.
- 2012 Feb;36(1):13-25.
- doi: 10.4093/dmj.2012.36.1.13
The current recommendations for the treatment of obese people include increased physical activity and reduced calories intake. When the behavioral approach is not sufficient, a pharmacologic treatment is recommended. In... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Obesity in Patients with Diabetes Mellitus
-
Lee MJ, Kim SS
- KMID: 2411421
- J Korean Diabetes.
- 2017 Dec;18(4):229-238.
- doi: 10.4093/jkd.2017.18.4.229
Both obesity and diabetes impose not only individual health problems, but also large socioeconomic burdens worldwide. Obesity is a major cause of insulin resistance and diabetes and is closely linked... -
- CITED
-
- Close
- SHARE
-
- Close
- 16 Cases of Anti-obesity Drug Intoxication Experienced in 4 Emergency Departments
-
Han SH, So BH, Jung WJ, Kim HM
- KMID: 1426779
- J Korean Soc Clin Toxicol.
- 2012 Dec;10(2):111-117.
PURPOSE: In Korea, few studies have examined the acute toxicity of anti-obesity drugs. The purpose of this study is to analyze the general characteristics and clinical aspect of acute anti-obesity... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacotherapy for Obesity
-
Joo JK, Lee KS
- KMID: 2325469
- J Menopausal Med.
- 2014 Dec;20(3):90-96.
- doi: 10.6118/jmm.2014.20.3.90
Obesity is an important risk factor for metabolic disease and various cancers. Treatments of obesity include lifestyle intervention, pharmacotherapy, and bariatric surgery. If weight loss with lifestyle intervention is only... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advances in Obesity Research and Management
-
Lee DH
- KMID: 2168212
- Hanyang Med Rev.
- 2012 Nov;32(4):213-218.
- doi: 10.7599/hmr.2012.32.4.213
Obesity is at epidemic proportions worldwide. Obesity is a significant risk factor for cardiovascular disease, diabetes, cancer and other chronic diseases. Initial lifestyle modification may be intended to induce 7-10%... -
- CITED
-
- Close
- SHARE
-
- Close
- Behavioral Intervention and Anti-Obesity Drug Therapy
-
Kim MK
- KMID: 2267840
- Korean J Med.
- 2013 May;84(5):624-628.
Obesity is associated with a reduction in life expectancy and an increase in mortality from cardiovascular diseases, cancer, and other causes. The U.S. Preventive Service Task Force (USPSTF) recommends screening... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Guidelines of Treatment of Obesity in Adults
-
Park YW
- KMID: 2065116
- J Korean Med Assoc.
- 2003 Apr;46(4):345-356.
- doi: 10.5124/jkma.2003.46.4.345
Obesity increases the risk of serious medical conditions such as type 2 diabetes and coronary heart disease. The risks associated with comorbidities can be reduced with a modest weight loss.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Dilated Cardiomyopathy with Massive Left Ventricular Thrombus after Use of a Sibutramine-Containing Slimming Product
-
Heo SH, Kang MH
- KMID: 2224820
- Korean Circ J.
- 2013 Sep;43(9):632-635.
- doi: 10.4070/kcj.2013.43.9.632
Sibutramine, which acts as an anti-obesity drug by inhibiting reuptake of serotonin and norepinephrine, has now been banned due to cardiovascular adverse effects. However, despite being banned, it is not... -
- CITED
-
- Close
- SHARE
-
- Close
- Weight Loss Drugs Recently Approved by the FDA
-
Lee CB
- KMID: 1430825
- J Korean Diabetes.
- 2013 Jun;14(2):58-62.
- doi: 10.4093/jkd.2013.14.2.58
There have been many advances in obesity treatment, including life-style modification and pharmacological and surgical treatments. It seems that the most remarkable advances in obesity treatment are those of pharmacological... -
- CITED
-
- Close
- SHARE
-
- Close
- Update on Anti-obesity Medications
-
Park KH
- KMID: 1958314
- J Korean Med Assoc.
- 2005 Sep;48(9):896-903.
- doi: 10.5124/jkma.2005.48.9.896
Obesity results from an imbalance between energy intake and energy expenditure. Drugs can shift this balance in a favorable way by reducing food intake, altering metabolism, and by increasing energy... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacotherapy for obesity
-
Kim KK
- KMID: 2190426
- J Korean Med Assoc.
- 2011 Apr;54(4):409-418.
- doi: 10.5124/jkma.2011.54.4.409
Due to its serious comorbidities and high prevalence, obesity is one of the heaviest burdens for public health. Although diet, exercise and behavioral modification are the first-line treatment for obesity,... -
- CITED
-
- Close
- SHARE
-
- Close
- Medical Management of Obesity
-
Lee SY
- KMID: 2383583
- Korean J Helicobacter Up Gastrointest Res.
- 2017 Jun;17(2):66-71.
- doi: 10.7704/kjhugr.2017.17.2.66
We, as health advocates, aim to raise awareness on the importance of a long-term approach for managing obesity as a chronic disease rather than merely a cosmetic issue. The cornerstone... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-obesity and LDL-cholesterol lowering effects of silkworm hemolymph in C57BL/6N mice fed high fat diet
-
Nam YR, Ko YE, Ly SY
- KMID: 2415216
- J Nutr Health.
- 2018 Jun;51(3):201-207.
- doi: 10.4163/jnh.2018.51.3.201
PURPOSE: Obesity, a worldwide epidemic, is associated with insulin resistance, hyperlipidemia, hypertension, cardiovascular disease, and certain cancers. Many strategies, including natural alternative anti-obesity agents, are used widely to prevent obesity.... -
- CITED
-
- Close
- SHARE
-
- Close
